All In MedTech

Company

Bioventus

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

BVS

Nasdaq · Bioventus Inc.

Public float

$264M

Value of shares held by non-insiders on Jun 28, 2025

Revenue

$568M

Fiscal year ending Dec 31, 2025

Net income

$22.7M

Fiscal year ending Dec 31, 2025

R&D spending

$12.1M

Fiscal year ending Dec 31, 2025

Cash

$30.7M

As of Sep 26, 2026

Long-term debt

$211M

As of Sep 26, 2026

Shares outstanding

Not reported

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025–$2.1M––
2024–$2.4M––
2023–$778K––
2022–$5.8M––
2021$108M$1.6M––

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is free with an account

For Bioventus we have 2 shareholders with 5% or more.

Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.

Latest FDA decisions

The 8 newest of 9 since 2015.

Search the Clearance Tracker

8 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

10 more trials with a free account

Reports received

18

Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.

Malfunction reports

2

11% of reports

Injury reports

13

72% of reports

Death reports

2

11% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 231200
Jan 240000
Feb 240000
Mar 241100
Apr 243100
May 241000
Jun 240200
Jul 242100
Aug 240500
Sep 245300
Oct 240520
Nov 241200
Dec 240000
Jan 250600
Feb 251100
Mar 251500
Apr 250100
May 251000
Jun 250000
Jul 252500
Aug 250000
Sep 250111
Oct 250100
Nov 250000
Dec 251101
Jan 260100
Feb 261000
Mar 260100
Apr 260100
May 260200
Jun 260210
Jul 260310
Aug 260000
Sep 260100
Oct 260100
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

The full in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

3 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

1 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.